Masimo v Apple; mRNA battles; patent transactions data; latest Nokia injunction; IBM’s new CIPO; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.
MONDAY 10 April
Data dive: Masimo and Apple patent duel heats up in California courtroom. Read more here
TUESDAY 11 April
New Pfizer/BioNTech covid-19 lawsuit adds to complex web of mRNA disputes. Read more here
Data dive: Patent transactions plummet in Q4 2022 compared to same period in 2021. Read more here
WEDNESDAY 12 April
New rules in India allowing foreign lawyers met with mixed reaction in IP community. Read more here
Nokia wins German injunction against Vivo, mirroring Oppo dispute. Read more here
IAM’s top takeaways from day one of IPBC Europe 2023. Read more here
THURSDAY 13 April
Weekly column: On both sides of the Atlantic, patent policy is dictated by deep pockets not evidence. Read more here
Bristol-Myers Squibb and Dana-Farber settle landmark dispute. Read more here
Chinese mega-manufacturer TCL signs with Via Licensing. Read more here
FRIDAY 14 April
Madras High Court’s new IP division opens doors. Read more here
Interview: Meet the new leader of IBM’s IP monetisation team. Read more here
IPBC Europe day two key highlights. Read more here
SATURDAY 15 April
Opinion: Delaware judge's inquisition is headed down a dangerous path. Read more here